Stay informed with the latest litigation news. Explore now

IP Verse

In Re: Aflibercept Patent Litigation - 1:24-md-03103

Explore the details of the In Re: Aflibercept Patent Litigation case under case number 1:24-md-03103 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-md-03103
Filing Date
Apr 11, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Celltrion, Inc. -
BIOCON BIOLOGICS INC. -
Samsung Bioepis, CO., LTD., -
AMGEN USA, INC. -
Amgen, Inc. -
Amgen Inc. -
Regeneron Pharmaceuticals, Inc. -
AFLIBERCEPT PATENT LITIGATION -
Mylan Pharmaceuticals Inc. -
Formycon AG -
Sandoz Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 17, 2025JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (1 in CAC/2:25-cv-05499, 50 in MDL No. 3103) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 7/17/2025. Associated Cases: MDL No. 3103, CAC/2:25-cv-05499. (snc) (Entered: 07/17/2025)PACER Document
Jul 24, 2025Joint MOTION to Reschedule Preliminary Injunction Hearing by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 07/24/2025)PACER Document
Jul 25, 2025Request for Hearing on its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) Modified to make pending motion on 7/28/2025 (dk). (Entered: 07/25/2025)PACER Document
Jul 25, 2025MOTION for Leave to File Under Seal its Reply Memorandum in Support of its Motion to Dissolve the Preliminary Injunction by Formycon AG. (Attachments: # 1 Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/25/2025)PACER Document
Jul 28, 2025ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 579 ). Signed by Chief District Judge Thomas S. Kleeh on 07/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/28/2025)PACER Document
Jul 31, 2025MEMBER CASE OPENED: Case Transferred into the Northern District of West Virginia: District of California Central, 2:25-cv-05499, REGENERON PHARMACEUTICALS, INC. v. AMGEN INC. as NDWV case 1:25-cv-74 pursuant to 577 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) and filed the 24 Pretrial Order #1: INITIAL SCHEDULING CONFERENCE. (snc) (Entered: 07/31/2025)PACER Document